PS6 - 30. Fasting and Postprandial GLP-1 and GIP in Relation to Alanine Aminotransterase and Lipid Metabolism in the General Population

Hypertriglyceridaemia and increased amounts of liver fat are acknowledged cardiovascular risk factors, especially among type 2 diabetes patients. The incretins glucagonlike peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are known from their insulinotropic effects, but recent studies have shown effects on lipid metabolism and liver fat.